It is of interest that DOT1L can also be targeted in the leukemias devoid of KMT2A rearrangements [260]—or, even, in the KMT2-unrelated solid tumors—to suppress the proliferation and metastasis of breast cancer cells [261]. The gene discussed is DOT1L; the disease is leukemia.